DENALI ADVISORS LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 89 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$2,0000.0%1000.0%0.00%
-100.0%
Q4 2014$2,0000.0%1000.0%0.00%0.0%
Q3 2014$2,0001000.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders